The Hydration Pharmaceuticals Company Ltd
The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. The company sells its products under the Hydralyte brand through retail stores and online. The Hydration Pharmaceuticals Company Limited was founded in 2001 and is based in Melbourne, Australi… Read more
Market Cap & Net Worth: The Hydration Pharmaceuticals Company Ltd (HPC)
The Hydration Pharmaceuticals Company Ltd (AU:HPC) has a market capitalization of $1.07 Million (AU$1.72 Million) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #37319 globally and #1433 in its home market, demonstrating a -20.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying The Hydration Pharmaceuticals Company Ltd's stock price AU$0.00 by its total outstanding shares 430800926 (430.80 Million).
The Hydration Pharmaceuticals Company Ltd Market Cap History: 2021 to 2026
The Hydration Pharmaceuticals Company Ltd's market capitalization history from 2021 to 2026. Data shows change from $80.02 Million to $1.07 Million (-65.11% CAGR).
The Hydration Pharmaceuticals Company Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how The Hydration Pharmaceuticals Company Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.50x
The Hydration Pharmaceuticals Company Ltd's market cap is 1.50 times its annual revenue
0.36x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
1.80x
The Hydration Pharmaceuticals Company Ltd's market cap is 1.80 times its annual earnings
7.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $80.02 Million | $6.13 Million | -$8.97 Million | 13.06x | N/A |
| 2022 | $24.01 Million | $9.10 Million | -$10.61 Million | 2.64x | N/A |
| 2023 | $6.40 Million | $10.04 Million | -$8.10 Million | 0.64x | N/A |
| 2024 | $4.80 Million | $3.20 Million | $2.67 Million | 1.50x | 1.80x |
Competitor Companies of HPC by Market Capitalization
Companies near The Hydration Pharmaceuticals Company Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to The Hydration Pharmaceuticals Company Ltd by market ranking:
- Sysco Corporation (NYSE:SYY): Ranked #539 globally with a market cap of $39.40 Billion USD.
- US Foods Holding Corp (NYSE:USFD): Ranked #1004 globally with a market cap of $19.50 Billion USD.
- Performance Food Group Co (NYSE:PFGC): Ranked #1376 globally with a market cap of $13.01 Billion USD.
- Bunzl plc (PINK:BZLFF): Ranked #1823 globally with a market cap of $8.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #539 | Sysco Corporation | NYSE:SYY | $39.40 Billion | $82.51 |
| #1004 | US Foods Holding Corp | NYSE:USFD | $19.50 Billion | $88.96 |
| #1376 | Performance Food Group Co | NYSE:PFGC | $13.01 Billion | $84.61 |
| #1823 | Bunzl plc | PINK:BZLFF | $8.90 Billion | $41.45 |
The Hydration Pharmaceuticals Company Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, The Hydration Pharmaceuticals Company Ltd's market cap moved from $80.02 Million to $ 1.07 Million, with a yearly change of -65.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$1.07 Million | -20.00% |
| 2025 | AU$1.33 Million | -72.22% |
| 2024 | AU$4.80 Million | -25.00% |
| 2023 | AU$6.40 Million | -73.33% |
| 2022 | AU$24.01 Million | -70.00% |
| 2021 | AU$80.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of The Hydration Pharmaceuticals Company Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.07 Million USD |
| MoneyControl | $1.07 Million USD |
| MarketWatch | $1.07 Million USD |
| marketcap.company | $1.07 Million USD |
| Reuters | $1.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.